Literature DB >> 11017195

Protein 4.1R core domain structure and insights into regulation of cytoskeletal organization.

B G Han1, W Nunomura, Y Takakuwa, N Mohandas, B K Jap.   

Abstract

The crystal structure of the core domain (N-terminal 30 kDa domain) of cytoskeletal protein 4.1R has been determined and shows a cloverleaf-like architecture. Each lobe of the cloverleaf contains a specific binding site for either band 3, glycophorin C/D or p55. At a central region of the molecule near where the three lobes are joined are two separate calmodulin (CaM) binding regions. One of these is composed primarily of an alpha-helix and is Ca 2+ insensitive; the other takes the form of an extended structure and its binding with CaM is dramatically enhanced by the presence of Ca 2+, resulting in the weakening of protein 4.1R binding to its target proteins. This novel architecture, in which the three lobes bind with three membrane associated proteins, and the location of calmodulin binding sites provide insight into how the protein 4.1R core domain interacts with membrane proteins and dynamically regulates cell shape in response to changes in intracellular Ca2+ levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017195     DOI: 10.1038/82819

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  35 in total

Review 1.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

2.  The carboxyterminal EF domain of erythroid alpha-spectrin is necessary for optimal spectrin-actin binding.

Authors:  Catherine Korsgren; Samuel E Lux
Journal:  Blood       Date:  2010-06-28       Impact factor: 22.113

3.  Protein 4.1R self-association: identification of the binding domain.

Authors:  Carmen M Pérez-Ferreiro; Eva Lospitao; Isabel Correas
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

4.  Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence.

Authors:  Silvana Ficarra; Ester Tellone; Bruno Giardina; Roberto Scatena; Annamaria Russo; Francesco Misiti; M Elisabetta Clementi; Deborah Colucci; Ersilia Bellocco; Giuseppina Laganà; Davide Barreca; Antonio Galtieri
Journal:  J Membr Biol       Date:  2009-02-24       Impact factor: 1.843

5.  Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane.

Authors:  Marcela Salomao; Xihui Zhang; Yang Yang; Soohee Lee; John H Hartwig; Joel Anne Chasis; Narla Mohandas; Xiuli An
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-04       Impact factor: 11.205

6.  Cytoskeletal protein 4.1G binds to the third intracellular loop of the A1 adenosine receptor and inhibits receptor action.

Authors:  Dongcheng Lu; Henglin Yan; Timothy Othman; Christopher P Turner; Thomas Woolf; Scott A Rivkees
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

7.  Protein 4.2 binds to the carboxyl-terminal EF-hands of erythroid alpha-spectrin in a calcium- and calmodulin-dependent manner.

Authors:  Catherine Korsgren; Luanne L Peters; Samuel E Lux
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

8.  Alternatively spliced exon 5 of the FERM domain of protein 4.1R encodes a novel binding site for erythrocyte p55 and is critical for membrane targeting in epithelial cells.

Authors:  Pil-Soo Seo; Jong-Jin Jeong; Lixiao Zeng; Christos G Takoudis; Brendan J Quinn; Anwar A Khan; Toshihiko Hanada; Athar H Chishti
Journal:  Biochim Biophys Acta       Date:  2008-10-08

9.  The Structure of the talin head reveals a novel extended conformation of the FERM domain.

Authors:  Paul R Elliott; Benjamin T Goult; Petra M Kopp; Neil Bate; J Günter Grossmann; Gordon C K Roberts; David R Critchley; Igor L Barsukov
Journal:  Structure       Date:  2010-10-13       Impact factor: 5.006

10.  4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.

Authors:  Qin Yang; Min Zhu; Zi Wang; Hui Li; Weihua Zhou; Xiaojuan Xiao; Bin Zhang; Weixin Hu; Jing Liu
Journal:  Tumour Biol       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.